Category: Therapeutic Area
Therapeutic Area market research reports by The Insight Partners
-
Contract Research Organization Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services), Product Type (Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others), Type (In-house and Outsource), Application (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorder, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology, and Others), End User (Pharmaceutical and Biotech Companies, Medical Device Companies, Academic and Research Institutes, and Others) and Geography
The contract research organization market is expected to reach US$ 113.79 billion by 2031 from US$ 65.38 billion in 2024; the market is estimated to grow at a CAGR of 8.2% during 2025–2031. Major factors driving the market growth include increased outsourcing of R&D and rising demand for clinical tr ... Read More
-
Asia Pacific Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), and End User (Hospitals, Dermatology Centers, and Others)
The Asia Pacific hyperpigmentation disorder treatment market was valued at US$ 2,462.36 million in 2022 and is expected to reach US$ 4,468.99 million by 2030; it is estimated to register a CAGR of 7.7% from 2022 to 2030. Strategic Initiatives by Market Players Boost Asia Pacific Hyperpigmentation Di ... Read More
-
Asia Pacific Transient Protein Expression Market Forecast to 2031 - Regional Analysis - by Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
The Asia Pacific transient protein expression market was valued at US$ 181.05 million in 2023 and is expected to reach US$ 294.26 million by 2031; it is estimated to register a CAGR of 6.3% from 2023 to 2031. Plant-Based Expression Systems for Therapeutic Protein Production Boost Asia Pacific Transi ... Read More
-
Asia Pacific Traumatic Brain Injury Diagnostics Equipment Market Forecast to 2030 - Regional Analysis - by Techniques (Non-Invasive, Invasive, and Combination Techniques), Device (Imaging devices and Monitoring Devices), and End User (Hospitals and Clinics, Diagnostic Centers, and Others)
The Asia Pacific traumatic brain injury diagnostics equipment market was valued at US$ 362.82 million in 2022 and is expected to reach US$ 1,030.47 million by 2030; it is estimated to register a CAGR of 13.9% from 2022 to 2030. Growing Use of MRI over CT to Limit Inpatient Mortality and Marginally R ... Read More
-
South & Central America Transient Protein Expression Market Forecast to 2031 - Regional Analysis - by Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
The South & Central America transient protein expression market was valued at US$ 43.70 million in 2023 and is expected to reach US$ 64.23 million by 2031; it is estimated to register a CAGR of 4.9% from 2023 to 2031. Increasing Applications of Protein Expression Systems Fuel South & Central America ... Read More
-
Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Regional Analysis - by Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others]
The Middle East & Africa electronic patient-reported outcomes (ePROS) market was valued at US$ 23.79 million in 2023 and is expected to reach US$ 60.23 million by 2031; it is estimated to register a CAGR of 12.3% from 2023 to 2031. Integration of Artificial Intelligence and Machine Learning with ePR ... Read More
-
South & Central America Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), and End User (Hospitals and Clinics, Home Care, and Others)
The South & Central America non-invasive ventilation masks market was valued at US$ 80.24 million in 2023 and is expected to reach US$ 115.12 million by 2031; it is estimated to register a CAGR of 4.6% from 2023 to 2031. Increasing Adoption of NIV Masks Fuels South & Central America Non-Invasive Ven ... Read More
-
Middle East & Africa Traumatic Brain Injury Diagnostics Equipment Market Forecast to 2030 - Regional Analysis - by Techniques (Non-Invasive, Invasive, and Combination Techniques), Device (Imaging devices and Monitoring Devices), and End User (Hospitals and Clinics, Diagnostic Centers, and Others)
The Middle East & Africa traumatic brain injury diagnostics equipment market was valued at US$ 82.73 million in 2022 and is expected to reach US$ 149.57 million by 2030; it is estimated to register a CAGR of 7.7% from 2022 to 2030. Emergence of Portable Non-invasive Monitoring Devices to Diagnose TB ... Read More
-
Asia Pacific Neurorehabilitation Devices Market Forecast to 2031- Regional Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), and End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care)
The Asia Pacific neurorehabilitation devices market was valued at US$ 445.40 million in 2023 and is expected to reach US$ 1,399.71 million by 2031; it is estimated to register a CAGR of 15.4% from 2023 to 2031. Strategic Initiatives by Market Players Boost Asia Pacific Neurorehabilitation Devices Ma ... Read More
-
North America Neurorehabilitation Devices Market Forecast to 2031 - Regional Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), and End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care)
The North America neurorehabilitation devices market was valued at US$ 1,512.12 million in 2023 and is expected to reach US$ 3,891.70 million by 2031; it is estimated to register a CAGR of 12.5% from 2023 to 2031. Increasing Prevalence of Neurological Diseases Fuels North America Neurorehabilitation ... Read More
-
South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Regional Analysis - by Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others]
The South & Central America electronic patient-reported outcomes (ePROS) market was valued at US$ 32.06 million in 2023 and is expected to reach US$ 86.04 million by 2031; it is estimated to register a CAGR of 13.1% from 2023 to 2031. Rising Adoption of Telehealth and Remote Monitoring Fuels South & ... Read More
-
Asia Pacific Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), and End User (Hospitals and Clinics, Home Care, and Others)
The Asia Pacific non-invasive ventilation masks market was valued at US$ 433.81 million in 2023 and is expected to reach US$ 719.68 million by 2031; it is estimated to register a CAGR of 6.5% from 2023 to 2031. Increasing Adoption of NIV Masks Drives Asia Pacific Non-Invasive Ventilation Masks Marke ... Read More
-
Europe Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), and End User (Hospitals and Clinics, Home Care, and Others)
The Europe non-invasive ventilation masks market was valued at US$ 574.58 million in 2023 and is expected to reach US$ 922.02 million by 2031; it is estimated to register a CAGR of 6.1% from 2023 to 2031. Growing Inclination Towards Home Healthcare Drive Europe Cosmetic Preservatives Market A shift ... Read More
-
North America Traumatic Brain Injury Diagnostics Equipment Market Forecast to 2030 - Regional Analysis - by Techniques (Non-Invasive, Invasive, and Combination Techniques), Device (Imaging devices and Monitoring Devices), and End User (Hospitals and Clinics, Diagnostic Centers, and Others)
The North America traumatic brain injury diagnostics equipment market was valued at US$ 1,360.02 million in 2022 and is expected to reach US$ 3,340.17 million by 2030; it is estimated to register a CAGR of 11.9% from 2022 to 2030. Accelerated Demand for Advanced Diagnostic Equipment Fuels North Amer ... Read More
-
North America Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), and End User (Hospitals and Clinics, Home Care, and Others)
The North America non-invasive ventilation masks market was valued at US$ 902.92 million in 2023 and is expected to reach US$ 1,412.14 million by 2031; it is estimated to register a CAGR of 5.7% from 2023 to 2031. Increasing Prevalence of Respiratory Diseases Fuels North America Cosmetic Preservativ ... Read More
-
Europe Neurorehabilitation Devices Market Forecast to 2031 - Regional Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), and End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care)
The Europe neurorehabilitation devices market was valued at US$ 631.51 million in 2023 and is expected to reach US$ 1,509.96 million by 2031; it is estimated to register a CAGR of 11.5% from 2023 to 2031. Growing Number of Clinical Studies on Neurorehabilitation Devices Drives Europe Neurorehabilita ... Read More
-
Asia Pacific Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Regional Analysis - by Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others]
The Asia Pacific electronic patient-reported outcomes (ePROS) market was valued at US$ 157.62 million in 2023 and is expected to reach US$ 613.75 million by 2031; it is estimated to register a CAGR of 18.5% from 2023 to 2031. Rising Adoption of Telehealth and Remote Monitoring Boosts Asia Pacific El ... Read More
-
Europe Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Regional Analysis - by Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others]
The Europe electronic patient-reported outcomes (ePROS) market was valued at US$ 268.32 million in 2023 and is expected to reach US$ 889.08 million by 2031; it is estimated to register a CAGR of 16.2% from 2023 to 2031. Increasing Focus on Patient-Centered Care Drives Europe Electronic Patient-Repor ... Read More
-
North America Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Regional Analysis - by Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others]
The North America electronic patient-reported outcomes (ePROS) market was valued at US$ 361.98 million in 2023 and is expected to reach US$ 1,218.90 million by 2031; it is estimated to register a CAGR of 16.4% from 2023 to 2031. Emerging Applications of Electronic Patient-Reported Outcomes (ePROS) F ... Read More
-
Middle East & Africa Transient Protein Expression Market Forecast to 2031 - Regional Analysis - by Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
The Middle East & Africa transient protein expression market was valued at US$ 40.00 million in 2023 and is expected to reach US$ 56.92 million by 2031; it is estimated to register a CAGR of 4.5% from 2023 to 2031. Integration of Artificial Intelligence (AI) and Automation Technologies Bolster Middl ... Read More
-
Europe Traumatic Brain Injury Diagnostics Equipment Market Forecast to 2030 - Regional Analysis - by Techniques (Non-Invasive, Invasive, and Combination Techniques), Device (Imaging devices and Monitoring Devices), and End User (Hospitals and Clinics, Diagnostic Centers, and Others)
The Europe traumatic brain injury diagnostics equipment market was valued at US$ 1,204.03 million in 2022 and is expected to reach US$ 2,976.48 million by 2030; it is estimated to register a CAGR of 12.0% from 2022 to 2030. Quick and Effective Diagnosis for TBI Patients Drive Europe Traumatic Brain ... Read More
-
South & Central America Traumatic Brain Injury Diagnostics Equipment Market Forecast to 2030 - Regional Analysis - by Techniques (Non-Invasive, Invasive, and Combination Techniques), Device (Imaging devices and Monitoring Devices), and End User (Hospitals and Clinics, Diagnostic Centers, and Others)
The South & Central America traumatic brain injury diagnostics equipment market was valued at US$ 148.10 million in 2022 and is expected to reach US$ 375.50 million by 2030; it is estimated to register a CAGR of 12.3% from 2022 to 2030. Growing Use of MRI over CT to Limit Inpatient Mortality and Mar ... Read More
-
Middle East & Africa Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), and End User (Hospitals and Clinics, Home Care, and Others)
The Middle East & Africa non-invasive ventilation masks market was valued at US$ 60.54 million in 2023 and is expected to reach US$ 92.61 million by 2031; it is estimated to register a CAGR of 5.5% from 2023 to 2031. Rising Technological Advancements Bolster Middle East & Africa Non-Invasive Ventila ... Read More
-
South & Central America Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), and End User (Hospitals, Dermatology Centers, and Others)
The South & Central America hyperpigmentation disorder treatment market was valued at US$ 887.76 million in 2022 and is expected to reach US$ 1,484.28 million by 2030; it is estimated to register a CAGR of 6.6% from 2022 to 2030. Rise in Prevalence of Melasma Fuels South & Central America Hyperpigme ... Read More
-
Middle East & Africa Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), and End User (Hospitals, Dermatology Centers, and Others)
The Middle East & Africa hyperpigmentation disorder treatment market was valued at US$ 530.30 million in 2022 and is expected to reach US$ 894.55 million by 2030; it is estimated to register a CAGR of 6.8% from 2022 to 2030. Novel Products Based on PATH-3 Technology Bolster Middle East & Africa Hype ... Read More
Research Assistance
